
    
      monocentric prospective open-label randomized controlled trial at the ICU of the University
      Hospitals of Geneva (Switzerland).

      ICU patients eligible if they 18 yr old and had an AKI requiring CRRT Exclusion criteria
      Patients excluded if they had active hemorrhagic disorders or severe thrombocytopenia (<
      50x109/L), a history of heparin-induced thrombocytopenia, severe liver failure defined as a
      factor V <20% or were on the waiting list for liver transplantation.

      Treatment assignment Subjects enrolled into the trial randomly allocated to either heparin or
      citrate anticoagulation
    
  